Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Kids with vitiligo, psoriasis, or alopecia areata are more likely to experience anxiety, depression, and social challenges.

Androgenic alopecia significantly affects adults' quality of life, especially in men and employed individuals.

Keloids significantly reduce quality of life, and treating symptoms should be prioritized.

Most women with hair loss using 5% topical Minoxidil are satisfied with the treatment, but hair loss still affects their daily habits and social life.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

There is a significant need for better-validated quality of life tools in dermatology.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Seborrheic dermatitis lowers quality of life more for women, younger people, and those with more education.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Most hospitalized internal medicine patients have undiagnosed skin problems and want them treated.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

Skin treatment can lower life quality for patients with skin conditions.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Acne and hair loss in women can greatly lower their quality of life, but having polycystic ovarian syndrome does not.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

People with psoriasis and depression have lower BDNF levels, which could help measure depression in those with psoriasis.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Vitiligo patients should be routinely screened for thyroid disease and, if extensive or prolonged, also for RA, PA, and type 2 diabetes.

More people are using online platforms for hair loss treatment due to convenience and privacy.

Some patients using cold caps to prevent hair loss from chemotherapy got mild scalp injuries similar to frostbite.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

About 43% of people in Europe have had a skin condition in the past year, with fungal infections, acne, and eczema being the most common.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.